pubmed-article:3543028 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:3543028 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
pubmed-article:3543028 | lifeskim:mentions | umls-concept:C0815000 | lld:lifeskim |
pubmed-article:3543028 | lifeskim:mentions | umls-concept:C0034826 | lld:lifeskim |
pubmed-article:3543028 | lifeskim:mentions | umls-concept:C0597362 | lld:lifeskim |
pubmed-article:3543028 | lifeskim:mentions | umls-concept:C0547047 | lld:lifeskim |
pubmed-article:3543028 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:3543028 | pubmed:dateCreated | 1987-3-11 | lld:pubmed |
pubmed-article:3543028 | pubmed:abstractText | Muscarinic receptor-linked increases in intracellular free Ca2+ as measured with quin-2 and Ca2+ release from monolayers of cells have been measured in the human neuroblastoma cell line SH-SY5Y. Induction of differentiation with the phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA) leads to a decrease in the sensitivity of the cells to low concentrations of agonists with respect to the induced increase in cytosolic free Ca2+ and stimulation of Ca2+ efflux. No decrease in agonist binding affinity was observed when the displacement of a labelled antagonist, 3H-NMS, by a non-labelled agonist was studied. | lld:pubmed |
pubmed-article:3543028 | pubmed:language | eng | lld:pubmed |
pubmed-article:3543028 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3543028 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:3543028 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3543028 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3543028 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3543028 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3543028 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3543028 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3543028 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:3543028 | pubmed:month | Jan | lld:pubmed |
pubmed-article:3543028 | pubmed:issn | 0021-9541 | lld:pubmed |
pubmed-article:3543028 | pubmed:author | pubmed-author:AkermanK EKE | lld:pubmed |
pubmed-article:3543028 | pubmed:author | pubmed-author:ScottI GIG | lld:pubmed |
pubmed-article:3543028 | pubmed:author | pubmed-author:HeikkiläJ EJE | lld:pubmed |
pubmed-article:3543028 | pubmed:author | pubmed-author:SuominenL ALA | lld:pubmed |
pubmed-article:3543028 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:3543028 | pubmed:volume | 130 | lld:pubmed |
pubmed-article:3543028 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:3543028 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:3543028 | pubmed:pagination | 157-62 | lld:pubmed |
pubmed-article:3543028 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:3543028 | pubmed:meshHeading | pubmed-meshheading:3543028-... | lld:pubmed |
pubmed-article:3543028 | pubmed:meshHeading | pubmed-meshheading:3543028-... | lld:pubmed |
pubmed-article:3543028 | pubmed:meshHeading | pubmed-meshheading:3543028-... | lld:pubmed |
pubmed-article:3543028 | pubmed:meshHeading | pubmed-meshheading:3543028-... | lld:pubmed |
pubmed-article:3543028 | pubmed:meshHeading | pubmed-meshheading:3543028-... | lld:pubmed |
pubmed-article:3543028 | pubmed:meshHeading | pubmed-meshheading:3543028-... | lld:pubmed |
pubmed-article:3543028 | pubmed:meshHeading | pubmed-meshheading:3543028-... | lld:pubmed |
pubmed-article:3543028 | pubmed:meshHeading | pubmed-meshheading:3543028-... | lld:pubmed |
pubmed-article:3543028 | pubmed:meshHeading | pubmed-meshheading:3543028-... | lld:pubmed |
pubmed-article:3543028 | pubmed:meshHeading | pubmed-meshheading:3543028-... | lld:pubmed |
pubmed-article:3543028 | pubmed:meshHeading | pubmed-meshheading:3543028-... | lld:pubmed |
pubmed-article:3543028 | pubmed:year | 1987 | lld:pubmed |
pubmed-article:3543028 | pubmed:articleTitle | Differentiation-associated decrease in muscarinic receptor sensitivity in human neuroblastoma cells. | lld:pubmed |
pubmed-article:3543028 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:3543028 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3543028 | lld:pubmed |